ScholarIQanswers from OpenAlex

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure

PaperCitations, authors & open-access status

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure have?

ScholarIQcitation count

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure has 53 citations in the OpenAlex counts ScholarIQ stores.

When was Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure published?

ScholarIQyear

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure has 2022 year in the ScholarIQ index.

What is the open-access status of Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure?

ScholarIQoa status

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure has hybrid oa status in the ScholarIQ index.

What is the DOI of Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure?

ScholarIQdoi

The DOI for Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure is on the source record.

What is the PMID of Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure?

ScholarIQpmid

The PMID for Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure is on the source record.

What is the OpenAlex record for Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure?

ScholarIQopenalex

The OpenAlex for Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial